Skip to content

Hyperbaric OXygen therapy for ACute Acoustic Trauma; HOXACAT

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-517739-35-00
Enrollment
84
Registered
2024-10-24
Start date
Unknown
Completion date
2025-12-31
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute acoustic trauma

Brief summary

The absolute average hearing gain on all affected frequencies at one month of follow-up

Interventions

DRUGOXYGEN

Sponsors

Amsterdam UMC Stichting
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The absolute average hearing gain on all affected frequencies at one month of follow-up

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026